## **Core Concept**
The question tests knowledge of antibiotics effective against *Pseudomonas aeruginosa*, a Gram-negative bacterium known for its resistance to many antibiotics. This pathogen commonly causes infections in immunocompromised individuals and those with cystic fibrosis. Effective treatments typically involve specific classes of antibiotics.

## **Why the Correct Answer is Right**
Ceftazidime is a third-generation cephalosporin with a broad spectrum of activity, including effectiveness against *Pseudomonas aeruginosa*. It works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), ultimately leading to cell lysis and death. This mechanism is crucial for its bactericidal effect against *Pseudomonas*.

## **Why Each Wrong Option is Incorrect**
* **Option A:** While certain fluoroquinolones like ciprofloxacin have activity against *Pseudomonas*, the option is incomplete, making it hard to assess its accuracy directly. However, fluoroquinolones are not the first line and have varying degrees of effectiveness.
* **Option B:** This option is blank and cannot be evaluated.
* **Option D:** This option is also blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that *Pseudomonas aeruginosa* is inherently resistant to many antibiotics due to its impermeable cell envelope and the presence of efflux pumps. Therefore, antibiotics like ceftazidime, which are known for their activity against *Pseudomonas*, are critical in the treatment of infections caused by this organism, particularly in severe cases such as pneumonia in cystic fibrosis patients or hospital-acquired infections.

## **Correct Answer:** C. Ceftazidime.